Contrast developer Guerbet has signed a deal with Belgian software developer Icometrix to distribute that company's icobrain CT and MRI analysis software in France, Italy, and Brazil.
Icobrain helps radiologists and neurologists diagnose and monitor patients with neurological disorders such as multiple sclerosis, dementia, or brain injury, Guerbet said. It is available to market in the U.S., Canada, Brazil, Australia, Japan, and India.
The deal will allow Guerbet to expand its portfolio of augmented intelligence offerings beyond oncology, according to the firm.
